Drug Profile
Argipressin intranasal
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator DelSite Biotechnologies
- Class Antidiuretics; Antihaemorrhagics; Vasoconstrictors; Vasopressins
- Mechanism of Action Vasopressin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 15 Jul 2008 Preclinical trials in Heart failure in USA (Intranasal)